Metro Bank Holdings (MTRO)

Sector:

Banking

Index:

FTSE Small Cap

101.60p
   
  • Change Today:
      7.90p
  • 52 Week High: 103.00p
  • 52 Week Low: 28.80p
  • Currency: UK Pounds
  • Shares Issued: 672.86m
  • Volume: 12,409,829
  • Market Cap: £683.63m
  • RiskGrade: 336
  • Beta: 1.11

Sunday newspaper round-up: Renewi, Metro Bank, New homes

By Alexander Bueso

Date: Sunday 08 Oct 2023

LONDON (ShareCast) - (Sharecast News) - Some of Renewi's major shareholders are divided as to whether the recycling company should engage with Australian suitor Macquarie. One major shareholder has told Renewi's board that it should not until Macquarie raised its £636m bid, but another top ten shareholder told The Sunday Times that it should talk to the Australian outfit anyways. Macquarie has until 26 October to make a firm offer. - The Sunday Times
Metro Bank is engaged in marathon talks with its bondholders to clinch a refinancing deal before the market open in London. The lender is reportedly seeking a £600m lifeline and needs to refinance £350m of debt within a year. It just recently balked at a takeover approach from Shawbrook, according to Sky News. Failure to close a deal may force it to sell the majority of its mortgage book, analysts at Barclays estimated, assuming the loans were sold at face value, which would be a challenge if seen as a forced sale. - The Financial Mail on Sunday

Labour will set a target to build 1.5m new homes over the next five years, party leader Keir Starmer said. It would also strengthen guidance to ensure developers to ensure that enough affordable homes were included. His party would also review the regulations regarding building on the green belt. In parallel, shadow Chancellor Rachel Reeves told the Sunday Times a common sense approach was necessary when designating land as greenbelt and brownfield. - Guardian

GSK is preparing to reorganise its research teams, switching from a single unit to individual teams for three areas: vaccines and infectious diseases, respiratory and immunology and oncology. The teams would also focus on earlier-stage science and then pass promising treatments to development teams. The company said however that "very few" redundancies would result from the changes. - The Sunday Times

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

MTRO Market Data

Currency UK Pounds
Share Price 101.60p
Change Today 7.90p
% Change 8.43 %
52 Week High 103.00p
52 Week Low 28.80p
Volume 12,409,829
Shares Issued 672.86m
Market Cap £683.63m
Beta 1.11
RiskGrade 336

MTRO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
88.36% above the market average88.36% above the market average88.36% above the market average88.36% above the market average88.36% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Price Trend
85.54% above the market average85.54% above the market average85.54% above the market average85.54% above the market average85.54% above the market average
46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average
Income Not Available
Growth
27.00% above the market average27.00% above the market average27.00% above the market average27.00% above the market average27.00% above the market average
6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average

MTRO Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:28 638 @ 100.00p
16:11 156 @ 101.40p
15:49 38 @ 102.00p
15:39 176 @ 100.60p
15:47 595,306 @ 100.20p

MTRO Key Personnel

CEO Daniel Frumkin
Chair Robert Sharpe
CFO Marc Page

Top of Page